Terez, Rosabel T.
HRN: 21-64-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
CEFUROXIME 500MG (TAB)
07/25/2022
08/01/2022
PO
500mg
Q12
Endometritis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes